Purchase Order 75N94025P00641
- Not listed
- This federal contract award, valued at $11,550.24, was issued by the National Human Genome Research Institute, a civilian agency within the National Institutes of Health (NIH), to UK Biobank Limited, a non-profit organization based in the United Kingdom. The contract is for a 36-month extension to provide Tier 3 level access to UK Biobank's large-scale biomedical database, which contains de-identified genetic, lifestyle, and health information from over 500,000 participants in the UK. This...
- This is a firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. government, to UK Biobank LIMITED, a non-profit organization in the United Kingdom. The $10,433.80 contract provides a 36-month extension for Tier 2 data access fees, allowing researchers at various National Institutes of Health agencies to access UK Biobank's extensive database of anonymized genetic, lifestyle, and health information from over 500,000 UK...
- This firm fixed-price purchase order contract, valued at $12,369.70, was awarded by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH), to UK Biobank Limited, a non-profit organization. The contract provides Tier 3 access to UK Biobank's large-scale, de-identified biomedical database containing genetic, lifestyle, and health information from over 500,000 participants in the United Kingdom. This data access supports biomedical research projects across...
- This is a $12,120 firm fixed-price purchase order awarded by the National Cancer Institute, part of the National Institutes of Health, to UK Biobank Limited, a non-profit organization. The contract provides UK Biobank Limited's large-scale biomedical database containing de-identified genetic, lifestyle, and health information from over 500,000 UK participants as a research resource for approved scientific researchers to analyze. The award, with a completion date of February 6, 2026,...
- This purchase order awards UK Biobank Limited $12,934.99 to provide Tier 3 access fees under a potential value of the same amount. As a non-profit organization, the contractor will deliver its standard biobank datasets and related laboratory and testing services to the Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute in Bethesda, Maryland by November 14, 2024. The firm fixed price contract vehicle was awarded on November 15, 2023...
- This firm fixed-price purchase order contract was awarded by the National Eye Institute (NEI), a component of the National Institutes of Health (NIH), to UK Biobank Limited, a non-profit organization. The $11,630.34 contract provides access to UK Biobank's large-scale biomedical database containing genetic, lifestyle, and health information from over 500,000 UK participants. This biobank serves as a research resource for approved scientific studies, and the contract facilitates projects...
- This is a firm fixed-price purchase order awarded by the National Institute of Mental Health (NIMH), a civilian agency within the U.S. Department of Health and Human Services, to UK Biobank LIMITED, a non-profit organization in the United Kingdom. The contract, valued at $14,312.98, will be performed in Great Britain and has an ultimate completion date of June 27, 2026. The contract does not have a set-aside designation. UK Biobank LIMITED will provide the NIMH and other National Institutes of...
- UK Biobank Limited has been awarded a $13,500 purchase order by the National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, to provide laboratory and testing services. The firm fixed price contract runs from December 2023 through March 2026 and will be performed by UK Biobank in Great Britain. No additional details were provided on the original solicitation or work scope. The award does not appear to be associated with a...
- The National Institutes of Health's National Institute on Alcohol Abuse and Alcoholism awarded UK Biobank Limited a three-year, firm fixed price purchase order valued at approximately thirteen thousand three hundred eighty-eight U.S. dollars to provide access to the United Kingdom Biobank dataset. As the prime contractor, UK Biobank Limited will deliver its biomedical database of genetic and health information to support research efforts of the National Institute on Alcohol Abuse and Alcoholism....
- The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a $14,400 firm fixed price purchase order to SPT Labtech Limited of Great Britain, United Kingdom. The contract is to provide unspecified products or services in support of NIH/NICHD programs. Performance will take place in the United Kingdom over a four month period concluding on December 31, 2016. No set aside designation or subcontractors were...
The National Institute of Child Health and Human Development (NICHD) awarded a $12,000 firm fixed-price purchase order to UK Biobank LIMITED on September 23, 2025, for Tier 3 access to the organization's comprehensive biomedical research datasets. The contract, which carries no set-aside designation, is severable and will conclude by September 22, 2026. UK Biobank LIMITED, a non-profit organization registered in Stockport, United Kingdom, maintains one of the world's largest biobanks with de-identified genetic, lifestyle, and health information from over 500,000 UK participants. This award enables NICHD-supported researchers to access whole exome and genome data linked to electronic health records, supporting investigations into genetic variations, complex medical conditions, and population health trends across multiple research disciplines. This contract represents part of UK Biobank LIMITED's ongoing service delivery to the National Institutes of Health enterprise, which also includes partnerships with the National Cancer Institute, National Institute of Mental Health, National Heart Lung and Blood Institute, National Institute of Aging, and other NIH components. The firm fixed-price structure and moderate ceiling value are consistent with UK Biobank LIMITED's typical data access agreements, which generally range from $10,000 to $15,000 and provide researchers with critical resources for understanding disease mechanisms, age-related conditions, and population genetics. The performance location in Great Britain reflects the physical location of the biobank's research infrastructure and participant data repositories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.0k | 9/22/25 |